105 related articles for article (PubMed ID: 8786711)
1. S-(-)-ET 126: a potent and selective M1 antagonist in vitro and in vivo.
Ghelardini C; Bartolini A; Galeotti N; Teodori E; Gualtieri F
Life Sci; 1996; 58(12):991-1000. PubMed ID: 8786711
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
Davies RH; Scholes HE; Virdi S; Broadley KJ
J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
[TBL] [Abstract][Full Text] [Related]
4. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
[TBL] [Abstract][Full Text] [Related]
5. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.
Lambrecht G; Feifel R; Wagner-Röder M; Strohmann C; Zilch H; Tacke R; Waelbroeck M; Christophe J; Boddeke H; Mutschler E
Eur J Pharmacol; 1989 Sep; 168(1):71-80. PubMed ID: 2583233
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes.
Adachi S; Koike K; Takayanagi I
Pharmacology; 1996 Oct; 53(4):250-8. PubMed ID: 8958564
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptor subtypes in the submandibular gland and the urinary bladder of the rabbit: in vivo and in vitro functional comparisons of receptor antagonists.
Tobin G
J Auton Pharmacol; 1995 Dec; 15(6):451-63. PubMed ID: 8920162
[TBL] [Abstract][Full Text] [Related]
8. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
Eltze M
Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317
[TBL] [Abstract][Full Text] [Related]
9. Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human isolated colon.
Kerr PM; Hillier K; Wallis RM; Garland CJ
Br J Pharmacol; 1995 Aug; 115(8):1518-24. PubMed ID: 8564213
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of a novel, potent and selective M3 antagonist.
Ghelardini C; Bartolini A; Galeotti N; Bellucci C; Dei S; Gualtieri F
Life Sci; 1997; 61(13):1217-26. PubMed ID: 9324063
[TBL] [Abstract][Full Text] [Related]
11. On the functional role of muscarinic M2 receptors in cholinergic and purinergic responses in the rat urinary bladder.
Giglio D; Delbro DS; Tobin G
Eur J Pharmacol; 2001 Oct; 428(3):357-64. PubMed ID: 11689195
[TBL] [Abstract][Full Text] [Related]
12. Characterization of muscarinic receptors mediating vasodilation in guinea-pig ileum submucosal arterioles by the use of computer-assisted videomicroscopy.
Bungardt E; Vockert E; Feifel R; Moser U; Tacke R; Mutschler E; Lambrecht G; Surprenant A
Eur J Pharmacol; 1992 Mar; 213(1):53-61. PubMed ID: 1499657
[TBL] [Abstract][Full Text] [Related]
13. Contraction of guinea-pig gallbladder: muscarinic M3 or M4 receptors?
Eltze M; König H; Ullrich B; Grebe T
Eur J Pharmacol; 1997 Jul; 332(1):77-87. PubMed ID: 9298928
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta.
Jaiswal N; Lambrecht G; Mutschler E; Tacke R; Malik KU
J Pharmacol Exp Ther; 1991 Sep; 258(3):842-50. PubMed ID: 1716312
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens.
Eltze M
Eur J Pharmacol; 1988 Jul; 151(2):205-21. PubMed ID: 2844551
[TBL] [Abstract][Full Text] [Related]
16. Selective antagonists provide evidence that M1 muscarinic receptors may mediate carbachol-induced drinking in the rat.
Polidori C; Massi M; Lambrecht G; Mutschler E; Tacke R; Melchiorre C
Eur J Pharmacol; 1990 Apr; 179(1-2):159-65. PubMed ID: 2364977
[TBL] [Abstract][Full Text] [Related]
17. The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists.
Melchiorre C; Minarini A; Budriesi R; Chiarini A; Spampinato S; Tumiatti V
Life Sci; 1995; 56(11-12):837-44. PubMed ID: 10188783
[TBL] [Abstract][Full Text] [Related]
18. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ
Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648
[TBL] [Abstract][Full Text] [Related]
19. The design and pharmacology of novel selective muscarinic agonists and antagonists.
Lambrecht G; Gross J; Hacksell U; Hermanni U; Hildebrandt C; Hou X; Moser U; Nilsson BM; Pfaff O; Waelbroeck M
Life Sci; 1995; 56(11-12):815-22. PubMed ID: 10188780
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
Hirose H; Aoki I; Kimura T; Fujikawa T; Numazawa T; Sasaki K; Sato A; Hasegawa T; Nishikibe M; Mitsuya M; Ohtake N; Mase T; Noguchi K
J Pharmacol Exp Ther; 2001 May; 297(2):790-7. PubMed ID: 11303071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
